Media
The latest news, announcements and media resources
Here you will find a range of resources including our latest and archived press releases, information on our social media channels, and our photo and video library.
Key information
Press releases
- GSK announces intention to produce 1 billion doses of pandemic vaccine adjuvant in 2021 to support multiple COVID-19 vaccine collaborations
- DREAMM-2 and DREAMM-6 data at ASCO reinforce the potential of GSK’s investigational belantamab mafodotin in patients with relapsed/refractory multiple myeloma
- FDA grants priority review of Nucala for patients with Hypereosinophilic Syndrome (HES)
GSK US Twitter
-
GSKUS @GSKUS
We’re proud to share the data results from the DREAMM study program in #multiplemyeloma at #ASCO20. Learn more: gsk.to/3cd5PU0
about 9 hours ago -
GSKUS @GSKUS
We’re working with our partner Vir Biotechnology to identify and accelerate potential antibody therapies to fight the virus that causes #COVID19. Learn more: gsk.to/2TTePqO
about 11 hours ago
-
GSK in the US
GSK is dedicated to helping grow the US economy and supporting communities by creating high-quality jobs in areas like R&D, manufacturing, and sales.
-
Pharmaceuticals
Our Pharmaceuticals business is made up of innovative and established medicines and holds leading market positions in respiratory disease and HIV.
-
Vaccines
Our Vaccines business has a broad portfolio and innovative pipeline of vaccines to protect people of all ages. We deliver over two million vaccine doses per day to people living in over 160 countries.
-
Consumer Healthcare
Our Consumer Healthcare business develops and markets consumer preferred and expert recommended brands in the Oral health, Pain relief, Respiratory, Nutrition/gastro-intestinal and Skin health categories.
